Stark K S, Satler L F, Krucoff M W, Rackley C E, Kent K M
Division of Cardiology, Georgetown University Hospital, Washington, D.C. 20007.
J Am Coll Cardiol. 1990 Jan;15(1):78-82. doi: 10.1016/0735-1097(90)90179-s.
Patients undergoing coronary angioplasty have a 2% to 7% risk of requiring emergency coronary artery bypass graft surgery for impending infarction. These patients provide a unique model of early reperfusion because the exact time of compromise to blood flow and the composition of the reperfusion solution are known. However, the amount of myocardium salvaged is unknown. Between December 1981 and September 1985, 859 patients underwent coronary angioplasty. Forty-two patients had emergency surgery for objective evidence of impending infarction. Five patients died. Thirty-six patients were contacted for follow-up; 21 (58%) of 36 had a radionuclide ventriculogram performed at a mean of 39 +/- 13 months after surgery. These radionuclide studies were compared with the patient's preangioplasty contrast ventriculogram. One patient had a myocardial infarction 3 years after surgery. Eleven (55%) of the remaining 20 patients had a normal radionuclide ventriculogram at follow-up study (ejection fraction 65 +/- 9%). Five (25%) of the 20 patients had a depressed ejection fraction (46 +/- 4%) with wall motion abnormalities, but these were unchanged from the preangioplasty studies. Four patients (20%) had a significant decrease in ejection fraction over baseline (37 +/- 10%) with new wall motion abnormalities.
接受冠状动脉血管成形术的患者有2%至7%的风险因即将发生的心肌梗死而需要进行急诊冠状动脉旁路移植手术。这些患者提供了一个早期再灌注的独特模型,因为血流受损的确切时间和再灌注溶液的成分是已知的。然而,挽救的心肌量尚不清楚。1981年12月至1985年9月期间,859例患者接受了冠状动脉血管成形术。42例患者因即将发生心肌梗死的客观证据而接受了急诊手术。5例患者死亡。36例患者被联系进行随访;36例中的21例(58%)在术后平均39±13个月进行了放射性核素心室造影。这些放射性核素研究与患者血管成形术前的对比心室造影进行了比较。1例患者术后3年发生心肌梗死。其余20例患者中有11例(55%)在随访研究中放射性核素心室造影正常(射血分数65±9%)。20例患者中有5例(25%)射血分数降低(46±4%)并有室壁运动异常,但与血管成形术前研究相比无变化。4例患者(20%)射血分数较基线显著降低(37±10%)并有新的室壁运动异常。
1) 在因血管成形术失败而接受急诊旁路移植术存活的患者中,3年随访研究时左心室功能无变化的几率为80%;2) 这些数据表明,在这种情况下,对即将发生的心肌梗死进行早期血运重建与良好的晚期结果相关;3) 该患者群体为研究人类模型中早期再灌注的影响提供了独特的机会。